Atlas FDA

NxStage Dialysate Sack (SAK) with Concentrate for Use with PureFlow SL REF: SAK-304 Lactate 45, Potassium 2, Sodium 140,

FDA device recall Z-1857-2014 · posted 2014-06-24 · Terminated

Recall details

Recalling firm
NxStage Medical, Inc.
Reason for recall
SAK Dialysate Concentrate contain aluminum levels which exceed internal product specification
Action taken
NxStage issued Initial recall letter dated 5/14/14 to dialysis centers. An error was noted and an updated letter dated 5/15/14 was resent to dialysis centers. The updated 5/15/14 letter was emailed to all current active PureFlow SL patients who had provided an email address followed by UPS next business day letter sent to all current active PureFlow SL patients. Accounts are requested to examine inventory and remove product. Contact NxStage Customer Service to arrange for return of all affected product and for replacement product to be sent. If you have any questions or comments, please feel free to contact NxStage Customer Service at 1-866-NXSTAGE (1-866-697-8243).
Root cause
Material/Component Contamination
Status
Terminated
Product code
FKR
Quantity affected
16,625 cases
Distribution
Worldwide Distribution - USA (nationwide) and Internationally to France, Netherlands, Spain, Sweden, and the UK.
Date initiated
2014-05-14
Date posted
2014-06-24
Date terminated
2017-03-13
Location
Lawrence, MA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
NXSTAGE PUREFLOW SL (K140571)Nxstage Medical, Inc.2014-05-15
NXSTAGE PUREFLOW SL (K111174)Nxstage Medical, Inc.2011-09-19